From Analysis:
Sleep disruption as cause and consequence of neurodegeneration
Sleep disruption as cause and consequence of neurodegeneration
These hypotheses emerged from the same multi-agent debate that produced this hypothesis.
Molecular Mechanism and Rationale
The hypocretin-neurogenesis coupling therapy targets the intricate molecular network connecting the hypocretin (orexin) system to adult hippocampal neurogenesis through multiple converging pathways. Hypocretin-1 (HCRT-1) and hypocretin-2 (HCRT-2), derived from the HCRT gene, are neuropeptides produced exclusively by approximately 10,000-20,000 neurons in the lateral hypothalamus. These peptides bind to two G-protein coupled receptors: hypocretin receptor 1 (HCRTR1) and hypocretin receptor 2 (HCRTR2), which are differentially distributed throughout the brain with particularly high expression in the hippocampal dentate gyrus.
Curated pathway diagram from expert analysis
graph TD
A["HCRT gene<br/>expression"]
B["Hypocretin-1 and<br/>Hypocretin-2<br/>peptides"]
C["HCRTR1 receptor<br/>binding"]
D["HCRTR2 receptor<br/>binding"]
E["Gq/11 protein<br/>activation"]
F["Gs protein<br/>activation"]
G["PLC activation<br/>and IP3/DAG<br/>production"]
H["cAMP elevation<br/>and PKA<br/>activation"]
I["Calcium release<br/>and PKC<br/>activation"]
J["CREB<br/>phosphorylation"]
K["BDNF and<br/>neurotrophin<br/>expression"]
L["Adult hippocampal<br/>neurogenesis"]
M["Cognitive function<br/>improvement"]
N["Neurodegeneration<br/>progression"]
A -->|"peptide synthesis"| B
B -->|"receptor binding"| C
B -->|"receptor binding"| D
C -->|"signal transduction"| E
D -->|"signal transduction"| F
E -->|"downstream signaling"| G
F -->|"downstream signaling"| H
G -->|"second messengers"| I
H -->|"convergent pathway"| J
I -->|"convergent pathway"| J
J -->|"transcriptional activation"| K
K -->|"promotes"| L
L -->|"enhances"| M
L -->|"counteracts"| N
classDef normal fill:#4fc3f7,stroke:#333,stroke-width:2px
classDef therapeutic fill:#81c784,stroke:#333,stroke-width:2px
classDef pathology fill:#ef5350,stroke:#333,stroke-width:2px
classDef outcome fill:#ffd54f,stroke:#333,stroke-width:2px
classDef genetic fill:#ce93d8,stroke:#333,stroke-width:2px
class A genetic
class B,C,D,E,F,G,H,I normal
class J,K,L therapeutic
class M,N outcome
AlphaFold predicted structure available for O43612
View AlphaFold StructureIn this paper we report the steady-state optical properties of a series of site-directed mutants in the Fenna-Matthews-Olson (FMO) complex of Chlorobaculum tepidum, a photosynthetic green sulfur bacterium. The FMO antenna complex has historically been used as a model system for energy transfer due to the water-soluble nature of the protein, its stability at room temperature, as well as the availability of high-resolution structural data. Eight FMO mutants were constructed with changes in the environment of each of the bacteriochlorophyll a pigments found within each monomer of the homotrimeric FMO complex. Our results reveal multiple changes in low temperature absorption, as well as room temperature CD in each mutant compared to the wild-type FMO complex. These datasets were subsequently used to model the site energies of each pigment in the FMO complex by employing three different Hamiltonians from the literature. This enabled a basic approximation of the site energy shifts imparted o
IMPORTANCE: IgG4-related hypertrophic pachymeningitis (IgG4-RHP) is an increasingly recognized manifestation of IgG4-related disease, a fibroinflammatory condition that can affect virtually any organ. It is estimated that IgG4-RHP may account for a high proportion of cases of hypertrophic pachymeningitis once considered idiopathic. OBJECTIVE: To summarize the current knowledge on IgG4-RHP including its pathological, clinical, and radiological presentations. Particular emphasis is placed on diagnostic and therapeutic implications. EVIDENCE REVIEW: This review is based on 21 reports published in the English medical literature since 2009. PubMed was searched with the following terms: IgG4, pachymeningitis, IgG4-related pachymeningitis, IgG4-related disease, IgG4-related, and IgG4 meningitis. Only cases with biopsy-proven IgG4-RHP were considered and included in this review. FINDINGS: Little is known with certainty regarding the pathogenesis of IgG4-RHP. The presence of oligoclonally restr
Single nucleotide polymorphisms (SNPs) in two genes regulating insulin secretion, SLC2A2 (encoding GLUT2) and ABCC8 (encoding SUR1), were associated with the conversion from impaired glucose tolerance (IGT) to type 2 diabetes (T2D) in the Finnish Diabetes Prevention Study (DPS). We determined whether physical activity (PA), assessed annually with a questionnaire, modified the association of SNPs in SLC2A2 and ABCC8 with the conversion to T2D in the combined intervention and control groups of the DPS. Finnish overweight subjects with IGT (N = 479) were followed for an average of 4.1 yr. The interaction of the SNPs with the change in PA on the conversion to T2D was assessed using Cox regression with adjustments for the other components of the intervention (dietary changes, weight reduction). The carriers of the common homozygous genotype of rs5393, rs5394, or rs5404 of SLC2A2 and rs3758947 of ABCC8 who were in the lower third of the change in moderate-to-vigorous PA during the follow-up
BACKGROUND: In vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) treatments conventionally consist of a fresh embryo transfer, possibly followed by one or more cryopreserved embryo transfers in subsequent cycles. An alternative option is to freeze all suitable embryos and transfer cryopreserved embryos in subsequent cycles only, which is known as the 'freeze all' strategy. This is the first update of the Cochrane Review on this comparison. OBJECTIVES: To evaluate the effectiveness and safety of the freeze all strategy compared to the conventional IVF/ICSI strategy in women undergoing assisted reproductive technology. SEARCH METHODS: We searched the Cochrane Gynaecology and Fertility Group Trials Register, CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL, and two registers of ongoing trials from inception until 23 September 2020 for relevant studies, checked references of publications found, and contacted study authors to obtain additional data. SELECTION CRITERIA: Two revi
Microglia have critical roles not only in neural development and homeostasis, but also in neurodegenerative and neuroinflammatory diseases of the central nervous system1-4. These highly diverse and specialized functions may be executed by subsets of microglia that already exist in situ, or by specific subsets of microglia that develop from a homogeneous pool of cells on demand. However, little is known about the presence of spatially and temporally restricted subclasses of microglia in the central nervous system during development or disease. Here we combine massively parallel single-cell analysis, single-molecule fluorescence in situ hybridization, advanced immunohistochemistry and computational modelling to comprehensively characterize subclasses of microglia in multiple regions of the central nervous system during development and disease. Single-cell analysis of tissues of the central nervous system during homeostasis in mice revealed specific time- and region-dependent subtypes of
Anderson disease (ANDD) or chylomicron retention disease (CMRD) is a rare, hereditary lipid malabsorption syndrome associated with mutations in the SAR1B gene that is characterized by failure to thrive and hypocholesterolemia. Although the SAR1B structure has been resolved and its role in formation of coat protein II (COPII)-coated carriers is well established, little is known about the requirement for SAR1B during embryogenesis. To address this question, we have developed a zebrafish model of Sar1b deficiency based on antisense oligonucleotide knockdown. We show that zebrafish sar1b is highly conserved among vertebrates; broadly expressed during development; and enriched in the digestive tract organs, brain, and craniofacial skeleton. Consistent with ANDD symptoms of chylomicron retention, we found that dietary lipids in Sar1b-deficient embryos accumulate in enterocytes. Transgenic expression analysis revealed that Sar1b is required for growth of exocrine pancreas and liver. Furthermo
We report a high spatial resolution mass spectrometry (MS) system that allows us to image live hippocampal tissue slices under open-air atmospheric pressure (AP) and ambient temperature conditions at the subcellular level. The method is based on an efficient desorption process by femtosecond (fs) laser assisted with nanoparticles and a subsequent ionization step by applying nonthermal plasma, termed AP nanoparticle and plasma assisted laser desorption ionization (AP-nanoPALDI) MS method. Combining the AP-nanoPALDI with microscopic sample scanning, MS imaging with spatial resolution of 2.9 µm was obtained. The observed AP-nanoPALDI MS imaging clearly revealed the differences of molecular composition between the apical and basal dendrite regions of a hippocampal tissue. In addition, the AP-nanoPALDI MS imaging showed the decrease of cholesterol in hippocampus by treating with methyl β-cyclodextrin, which exemplifies the potential of AP-nanoPALDI for live tissue imaging for various biomed
The conservation of sleep across all animal species suggests that sleep serves a vital function. We here report that sleep has a critical function in ensuring metabolic homeostasis. Using real-time assessments of tetramethylammonium diffusion and two-photon imaging in live mice, we show that natural sleep or anesthesia are associated with a 60% increase in the interstitial space, resulting in a striking increase in convective exchange of cerebrospinal fluid with interstitial fluid. In turn, convective fluxes of interstitial fluid increased the rate of β-amyloid clearance during sleep. Thus, the restorative function of sleep may be a consequence of the enhanced removal of potentially neurotoxic waste products that accumulate in the awake central nervous system.
Sewage samples have been investigated to study the norovirus concentrations in sewage or the genotypes of noroviruses circulating in human populations. However, the statistical relationship between the concentration of the virus and the number of infected individuals and the clinical importance of genotypes or strains detected in sewage are unclear. In this study, we carried out both environmental and clinical surveillance of noroviruses for 3 years, 2013 to 2016. We performed cross-correlation analysis of the concentrations of norovirus GI or GII in sewage samples collected weekly and the reported number of gastroenteritis cases. Norovirus genotypes in sewage were also analyzed by pyrosequencing and compared with those identified in stool samples. The cross-correlation analysis found the peak coefficient (R = 0.51) at a lag of zero, indicating that the variation in the GII concentration, expressed as the log10 number of copies per milliliter, was coincident with that in the gastroente
Hypocretin/Orexin (HCRT/OX) and dopamine (DA) are both key effectors of salience processing, reward and stress-related behaviors and motivational states, yet their respective roles and interactions are poorly delineated. We inactivated HCRT-to-DA connectivity by genetic disruption of Hypocretin receptor-1 (Hcrtr1), Hypocretin receptor-2 (Hcrtr2), or both receptors (Hcrtr1&2) in DA neurons and analyzed the consequences on vigilance states, brain oscillations and cognitive performance in freely behaving mice. Unexpectedly, loss of Hcrtr2, but not Hcrtr1 or Hcrtr1&2, induced a dramatic increase in theta (7-11 Hz) electroencephalographic (EEG) activity in both wakefulness and rapid-eye-movement sleep (REMS). DAHcrtr2-deficient mice spent more time in an active (or theta activity-enriched) substate of wakefulness, and exhibited prolonged REMS. Additionally, both wake and REMS displayed enhanced theta-gamma phase-amplitude coupling. The baseline waking EEG of DAHcrtr2-deficient mice exhibite
Multiple lines of evidence indicate that hypocretin/orexin (HCRT) participates in the regulation of arousal and arousal-related process. For example, HCRT axons and receptors are found within a variety of arousal-related systems. Moreover, when administered centrally, HCRT exerts robust wake-promoting actions. Finally, a dysregulation of HCRT neurotransmission is associated with the sleep/arousal disorder, narcolepsy. Combined, these observations suggested that HCRT might be a key transmitter system in the regulation of waking. Nonetheless, subsequent evidence indicates that HCRT may not play a prominent role in the initiation of normal waking. Instead HCRT may participate in a variety of processes such as consolidation of waking and/or coupling metabolic state with behavioral state. Additionally, substantial evidence suggests a potential involvement of HCRT in high-arousal conditions, including stress. Thus, HCRT neurotransmission is closely linked to high-arousal conditions, includin
Current models of sleep/wake regulation posit that Hypocretin (Hcrt)-expressing neurons in the lateral hypothalamus promote and stabilize wakefulness by projecting to subcortical arousal centers. However, the critical downstream effectors of Hcrt neurons are unknown. Here we use optogenetic, pharmacological, and computational tools to investigate the functional connectivity between Hcrt neurons and downstream noradrenergic neurons in the locus coeruleus (LC) during nonrapid eye movement (NREM) sleep. We found that photoinhibiting LC neurons during Hcrt stimulation blocked Hcrt-mediated sleep-to-wake transitions. In contrast, when LC neurons were optically stimulated to increase membrane excitability, concomitant photostimulation of Hcrt neurons significantly increased the probability of sleep-to-wake transitions compared with Hcrt stimulation alone. We also built a conductance-based computational model of Hcrt-LC circuitry that recapitulates our behavioral results using LC neurons as t
The neuropeptide nociceptin/orphanin FQ (N/OFQ), acting on its receptors (NOP), modulates a variety of biological functions and neurobehavior including nociception, stress responses, water and food-intake, locomotor activity, and spatial attention. N/OFQ is conventionally regarded as an "antiopiate" peptide in the brain because central administration of N/OFQ attenuates stress-induced analgesia (SIA) and produces anxiolytic effects. However, naloxone-irreversible SIA and anxiolytic action are unlikely to be mediated by the opiate system. Both N/OFQ and NOP receptors are expressed most abundantly in the hypothalamus, where two other neuropeptides, the hypocretins/orexins (Hcrts), are exclusively synthesized in the lateral hypothalamic area. N/OFQ and Hcrt regulate most cellular physiological responses in opposite directions (e.g., ion channel modulation and second messenger coupling), and produce differential modulations for almost all neurobehavior assessed, including sleep/wake, locom
We investigated relationships among immune, metabolic, and sleep abnormalities in mice with non-metastatic mammary cancer. Tumor-bearing mice displayed interleukin-6 (IL-6)-mediated peripheral inflammation, coincident with altered hepatic glucose processing and sleep. Tumor-bearing mice were hyperphagic, had reduced serum leptin concentrations, and enhanced sensitivity to exogenous ghrelin. We tested whether these phenotypes were driven by inflammation using neutralizing monoclonal antibodies against IL-6; despite the reduction in IL-6 signaling, metabolic and sleep abnormalities persisted. We next investigated neural populations coupling metabolism and sleep, and observed altered activity within lateral-hypothalamic hypocretin/orexin (HO) neurons. We used a dual HO-receptor antagonist to test whether increased HO signaling was causing metabolic abnormalities. This approach rescued metabolic abnormalities and enhanced sleep quality in tumor-bearing mice. Peripheral sympathetic denervat
New neurons continue to be generated in the subgranular zone of the dentate gyrus of the adult mammalian hippocampus. This process has been linked to learning and memory, stress and exercise, and is thought to be altered in neurological disease. In humans, some studies have suggested that hundreds of new neurons are added to the adult dentate gyrus every day, whereas other studies find many fewer putative new neurons. Despite these discrepancies, it is generally believed that the adult human hippocampus continues to generate new neurons. Here we show that a defined population of progenitor cells does not coalesce in the subgranular zone during human fetal or postnatal development. We also find that the number of proliferating progenitors and young neurons in the dentate gyrus declines sharply during the first year of life and only a few isolated young neurons are observed by 7 and 13 years of age. In adult patients with epilepsy and healthy adults (18-77 years; n = 17 post-mortem sampl
Despite the widespread use of nanotechnology in radio-imaging applications, lipoprotein based delivery systems have received only limited attention so far. These studies involve the synthesis of a novel hydrophobic radio-imaging tracer consisting of a hydrazinonicotinic acid (HYNIC)-N-dodecylamide and 99mTc conjugate that can be encapsulated into rHDL nanoparticles (NPs). These rHDL NPs can selectively target the Scavenger Receptor type B1 (SR-B1) that is overexpressed on most cancer cells due to excess demand for cholesterol for membrane biogenesis and thus can target tumors in vivo. We provide details of the tracer synthesis, characterization of the rHDL/tracer complex, in vitro uptake, stability studies and in vivo application of this new radio-imaging approach.
OBJECTIVE: To examine the reciprocal longitudinal associations between depression or anxiety with work-related injury (WRI) at a large employer in the southwestern United States. METHOD: Three administrative datasets (2011-2013) were merged: employee eligibility, medical and prescription claims, and workers' compensation claims. The sample contained 69 066 active employees. Depression and anxiety were defined as episodes of medical visits care (ie, claims) with corresponding ICD-9-CM codes. For an individual's consecutive claims, a new case of depression or anxiety was defined if more than 8 weeks have passed since the prior episode. The presence of a workers' compensation injury claim was used to identify WRI. Three-wave (health plan years 2011 or T1, 2012 or T2, and 2013 or T3) autoregressive cross-lagged models were used to estimate whether depression or anxiety predicted WRI, also if WRI predicted depression or anxiety in the following year(s). RESULTS: Depression predicted injury
BACKGROUND: In vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) treatments conventionally consist of a fresh embryo transfer, possibly followed by one or more cryopreserved embryo transfers in subsequent cycles. An alternative option is to freeze all suitable embryos and transfer cryopreserved embryos in subsequent cycles only, which is known as the 'freeze all' strategy. This is the first update of the Cochrane Review on this comparison. OBJECTIVES: To evaluate the effectiveness and safety of the freeze all strategy compared to the conventional IVF/ICSI strategy in women undergoing assisted reproductive technology. SEARCH METHODS: We searched the Cochrane Gynaecology and Fertility Group Trials Register, CENTRAL, MEDLINE, Embase, PsycINFO, CINAHL, and two registers of ongoing trials from inception until 23 September 2020 for relevant studies, checked references of publications found, and contacted study authors to obtain additional data. SELECTION CRITERIA: Two revi
OBJECTIVES: To explore inpatients experiences and views with regard to antibiotics in five European hospitals. METHODS: Qualitative study where a patient-centred framework was used to explore inpatients' experiences concerning antibiotic treatment. A purposeful sample of inpatients treated with antibiotics in five hospitals participated in interviews (all centres) and focus groups (Switzerland only). RESULTS: A total of 31 interviews (five in Belgium, ten in Croatia, nine in France, five in the Netherlands and two in Switzerland) and three focus groups (in Switzerland, 11 participants) were performed. The median age of participants was 61 years (range 33-86 years). The following main themes emerged: (a) patients trust doctors to take the best decisions for them even though communication concerning different antibiotic-related aspects is often insufficient, (b) patients feel that doctors do not prioritize communication due to time constraints and do not seem to adapt information based o
The global epidemic of prediabetes and diabetes has led to a corresponding epidemic of complications of these disorders. The most prevalent complication is neuropathy, of which distal symmetric polyneuropathy (for the purpose of this Primer, referred to as diabetic neuropathy) is very common. Diabetic neuropathy is a loss of sensory function beginning distally in the lower extremities that is also characterized by pain and substantial morbidity. Over time, at least 50% of individuals with diabetes develop diabetic neuropathy. Glucose control effectively halts the progression of diabetic neuropathy in patients with type 1 diabetes mellitus, but the effects are more modest in those with type 2 diabetes mellitus. These findings have led to new efforts to understand the aetiology of diabetic neuropathy, along with new 2017 recommendations on approaches to prevent and treat this disorder that are specific for each type of diabetes. In parallel, new guidelines for the treatment of painful di
Narcolepsy is a neurological disorder that afflicts 1 in 2000 individuals and is characterized by excessive daytime sleepiness and cataplexy-a sudden loss of muscle tone triggered by positive emotions. Features of narcolepsy include dysregulation of arousal state boundaries as well as autonomic and metabolic disturbances. Disruption of neurotransmission through the hypocretin/orexin (Hcrt) system, usually by degeneration of the HCRT-producing neurons in the posterior hypothalamus, results in narcolepsy. The cause of Hcrt neurodegeneration is unknown but thought to be related to autoimmune processes. Current treatments for narcolepsy are symptomatic, including wake-promoting therapeutics that increase presynaptic dopamine release and anticataplectic agents that activate monoaminergic neurotransmission. Sodium oxybate is the only medication approved by the US Food and Drug Administration that alleviates both sleep/wake disturbances and cataplexy. Development of therapeutics for narcoleps
STUDY OBJECTIVES: To investigate the cumulative effect of five consecutive nights of partial sleep deprivation (PSD) on a panel of cerebrospinal fluid (CSF) biomarkers in healthy adults. METHODS: A randomized, cross-over study conducted at the University of Gothenburg. The participants (N = 13) were healthy adults (20-40 years of age) with a normal sleeping pattern. The participants underwent a baseline sleep period consisting of five nights with 8 hr spent in bed. A subsequent period with PSD consisted of five nights of maximum 4 hr of sleep per night. Four participants were also subjected to a prolonged period of PSD consisting of eight nights with 4 hr of sleep per night. Sleep was monitored by means of observation, actigraphy, and continuous polysomnographic recordings. CSF samples were collected by routine lumbar puncture after each period. CSF biomarkers included the 38, 40, and 42 amino acid-long Aβ isoforms, total-τ, phospho-τ, orexin, monoamine metabolites (3-methoxy-4-hydroxy
Target: AQP4 (Aquaporin-4) and MTNR1A/1B (Melatonin receptors)
Supporting Evidence: Glymphatic system activity increases dramatically during sleep
Major Weaknesses:
| Event | Price | Change | Source | Time | |
|---|---|---|---|---|---|
| 📄 | New Evidence | $0.471 | ▲ 1.0% | evidence_batch_update | 2026-04-13 02:18 |
| 📄 | New Evidence | $0.466 | ▲ 3.2% | evidence_batch_update | 2026-04-13 02:18 |
| ⚖ | Recalibrated | $0.452 | ▼ 0.4% | 2026-04-12 10:15 | |
| ⚖ | Recalibrated | $0.453 | ▼ 2.1% | 2026-04-12 05:13 | |
| ⚖ | Recalibrated | $0.463 | ▼ 1.2% | 2026-04-10 15:58 | |
| ⚖ | Recalibrated | $0.469 | ▲ 1.4% | 2026-04-10 15:53 | |
| ⚖ | Recalibrated | $0.462 | ▲ 1.0% | 2026-04-08 18:39 | |
| ⚖ | Recalibrated | $0.457 | ▲ 5.9% | 2026-04-06 04:04 | |
| ⚖ | Recalibrated | $0.432 | ▼ 2.7% | 2026-04-04 16:38 | |
| ⚖ | Recalibrated | $0.444 | ▲ 1.2% | 2026-04-04 16:02 | |
| 📄 | New Evidence | $0.438 | ▲ 1.7% | evidence_batch_update | 2026-04-04 09:08 |
| ⚖ | Recalibrated | $0.431 | ▼ 6.9% | 2026-04-03 23:46 | |
| ⚖ | Recalibrated | $0.463 | ▲ 8.9% | 2026-04-02 21:55 | |
| ⚖ | Recalibrated | $0.425 | ▼ 11.9% | market_recalibrate | 2026-04-02 19:14 |
| 💬 | Debate Round | $0.482 | ▲ 0.7% | debate_engine | 2026-04-02 17:18 |
Molecular pathway showing key causal relationships underlying this hypothesis
graph TD
HCRTR2["HCRTR2"] -->|modulates via micr| CX3CR1["CX3CR1"]
HCRT["HCRT"] -->|associated with| neurodegeneration["neurodegeneration"]
HCRTR2_1["HCRTR2"] -->|participates in| Microglial_activation___T["Microglial activation / TREM2 signaling"]
HCRT_2["HCRT"] -->|participates in| Hypocretin_orexin_wakeful["Hypocretin/orexin wakefulness signaling"]
BMAL1["BMAL1"] -->|co discussed| HCRTR2_3["HCRTR2"]
BMAL1_4["BMAL1"] -->|co discussed| HCRT_5["HCRT"]
HCRTR2_6["HCRTR2"] -->|co discussed| CLOCK["CLOCK"]
HCRTR2_7["HCRTR2"] -->|co discussed| BDNF["BDNF"]
HCRTR2_8["HCRTR2"] -->|co discussed| AQP4["AQP4"]
HCRTR2_9["HCRTR2"] -->|co discussed| MTNR1A["MTNR1A"]
HCRTR2_10["HCRTR2"] -->|co discussed| CX3CR1_11["CX3CR1"]
HCRTR2_12["HCRTR2"] -->|co discussed| HCRT_13["HCRT"]
HCRTR2_14["HCRTR2"] -->|co discussed| CACNA1G["CACNA1G"]
HCRTR2_15["HCRTR2"] -->|co discussed| ADORA2A["ADORA2A"]
HCRTR2_16["HCRTR2"] -->|co discussed| ADRA2A["ADRA2A"]
style HCRTR2 fill:#ce93d8,stroke:#333,color:#000
style CX3CR1 fill:#ce93d8,stroke:#333,color:#000
style HCRT fill:#ce93d8,stroke:#333,color:#000
style neurodegeneration fill:#ef5350,stroke:#333,color:#000
style HCRTR2_1 fill:#ce93d8,stroke:#333,color:#000
style Microglial_activation___T fill:#81c784,stroke:#333,color:#000
style HCRT_2 fill:#ce93d8,stroke:#333,color:#000
style Hypocretin_orexin_wakeful fill:#81c784,stroke:#333,color:#000
style BMAL1 fill:#ce93d8,stroke:#333,color:#000
style HCRTR2_3 fill:#ce93d8,stroke:#333,color:#000
style BMAL1_4 fill:#ce93d8,stroke:#333,color:#000
style HCRT_5 fill:#ce93d8,stroke:#333,color:#000
style HCRTR2_6 fill:#ce93d8,stroke:#333,color:#000
style CLOCK fill:#ce93d8,stroke:#333,color:#000
style HCRTR2_7 fill:#ce93d8,stroke:#333,color:#000
style BDNF fill:#ce93d8,stroke:#333,color:#000
style HCRTR2_8 fill:#ce93d8,stroke:#333,color:#000
style AQP4 fill:#ce93d8,stroke:#333,color:#000
style HCRTR2_9 fill:#ce93d8,stroke:#333,color:#000
style MTNR1A fill:#ce93d8,stroke:#333,color:#000
style HCRTR2_10 fill:#ce93d8,stroke:#333,color:#000
style CX3CR1_11 fill:#ce93d8,stroke:#333,color:#000
style HCRTR2_12 fill:#ce93d8,stroke:#333,color:#000
style HCRT_13 fill:#ce93d8,stroke:#333,color:#000
style HCRTR2_14 fill:#ce93d8,stroke:#333,color:#000
style CACNA1G fill:#ce93d8,stroke:#333,color:#000
style HCRTR2_15 fill:#ce93d8,stroke:#333,color:#000
style ADORA2A fill:#ce93d8,stroke:#333,color:#000
style HCRTR2_16 fill:#ce93d8,stroke:#333,color:#000
style ADRA2A fill:#ce93d8,stroke:#333,color:#000
neurodegeneration | 2026-04-01 | completed